Position in CYTK
as of Mar 31, 2026
· filed May 19, 2026
Position Value
$308,326
+$87,059 QoQ
Shares Held
4,678
+48.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CIM INVESTMENT MANAGEMENT INC holds $2,638,068 across 8 Biotechnology names. CYTK ranks #5 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
5,930 | $558,131 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
8,492 | $548,837 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
452 | $349,233 | |
| 4 | ACAD |
Acadia Pharmaceuticals Inc
|
14,239 | $316,960 | |
| 5 | CYTK |
Cytokinetics Inc
This page
|
4,678 | $308,326 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
1,484 | $296,280 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,993 | $260,301 | |
| 8 | 12,537 | $0 |
All Filings in CYTK
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $308,326 | 4,678 | Shares | Sole | 2026-05-19 | |
| 2024-03-31 | $221,267 | 3,156 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $263,494 | 3,156 | Shares | Sole | 2024-02-16 | |
| No filing history on record for this holder in this stock. | ||||||